Market Highlights
The acute segment dominated the global appendicitis market, by type, and is projected to reach USD 9,518.69 Million by 2024 owing to the cost-effectiveness of the product. However, the chronic segment is projected to be the fastest-growing segment during the forecast period.
North America dominated the market, accounting for the largest share of the market in 2018, and the regional market is expected to register a CAGR of 39.8% during the review period. The European market was the second largest in 2018. The market is projected to reach USD 3,484.27 Million by the end of 2024, with Italy being the leading market.
The Global Appendicitis Market Size is estimated to be valued at USD 13,026.40 Million by 2024 and is expected to register a CAGR of 4.06% during the forecast period.
Segment Analysis
The global appendicitis market has been segmented based on type, diagnosis & treatment, end-user, and region. Based on type, the market has been divided into acute and chronic. The acute segment held the majority market share in 2018. However, the chronic segment is anticipated to be the fastest growing.
Based on diagnosis and treatment, the market is further sub-segmented as diagnosis and treatment. The diagnosis segment is further sub-segmented as ultrasound imaging, CT scan, and others. The diagnosis segment held the majority market share in 2018. Treatment segment is further sub-segmented into antibiotics and appendectomy. However, the treatment segment is expected to exhibit the highest CAGR.
On the basis of end-user, the market has been divided into hospitals & clinics and diagnostic centers. The hospitals & clinics segment accounted for the larger market share in 2018. However, the diagnostic centers segment is expected to exhibit the higher CAGR during the forecast period.
Market Players
Market Research Future (MRFR) recognizes Johnson & Johnson Services Inc (US), Pfizer Inc (US), Lupin (India), Siemens (Germany), Koninklijke Philips NV (Netherlands), Becton, Dickinson and Company (US), B. Braun Melsungen AG (Germany), Cook (US), Medtronic (Ireland), Teva Pharmaceutical Industries Ltd (Israel) as the key players in the global appendicitis market.
https://www.marketresearchfuture.com/reports/appendicitis-market-5287